Delivery Order SPE2DB22D2007-SPE2DB25FJ0YU
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for 0.5mL Vaxelis vaccine syringes, valued at $6,930.55 under a firm fixed price contract type. The award was made on May 12, 2025, with an ultimate completion date of May 13, 2025. The contractor is based in Conshohocken, Pennsylvania, which also serves as the place of performance. No set-aside designation was utilized in this competitive award. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) under a firm fixed-price contract valued at $1,947.21, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency awarded a $3,836.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for Vaxelis vaccine syringes in 0.5ML quantities. The order, which is non-set-aside and competitively awarded, has an ultimate completion date of April 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 6, 2025, by the Defense Logistics Agency (DLA) for the supply of Vaxelis vaccine vials (0.5 mL) with a contract value of $6,173.93 and an ultimate completion date of August 7, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This...
- On September 12, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 0.5ML Vaxelis vaccine syringes with a ceiling value of $4,476.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order valued at $24,239.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 14, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,493.95 to AmerisourceBergen Drug Corp for the supply of Vaxelis vaccine syringes (0.5ml) under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Performance will be executed from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $5,791.57 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,207.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 0.5mL VAXELIS vaccine syringes, with a performance period through November 5, 2024. This Delivery Order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
- The Defense Logistics Agency awarded a delivery order valued at $13,888.38 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by July 18, 2025, one day after the award date of July 17, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ0YUDelivery Order
AmerisourceBergen Drug Corp was awarded a $4,617.45 delivery order by the Defense Logistics Agency on April 24, 2025, for Vaxelis vaccine syringes (0.5mL). The contract, designated as a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award is unset-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company holds extensive federal contract awards through the Defense Logistics Agency Medical Supply Chain, demonstrating capability to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order for vaccine syringes supports the DLA's mission to supply medical commodities across the global military healthcare enterprise and reflects the company's ongoing role as a primary pharmaceutical vendor for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/24/25 |